Introduction:
The pharmaceutical industry in China has been rapidly growing in recent years, with a focus on generic drug serialization and track-and-trace solutions. With increasing regulations and demand for safe and authentic medications, the market for serialization and track-and-trace solutions in China is on the rise. According to recent statistics, China’s pharmaceutical industry is expected to reach a production volume of over 1 trillion RMB by 2025, making it one of the largest markets in the world.
Top 10 Generic Drug Serialization & Track-and-Trace Solution Providers in China:
1. Sinopharm
Sinopharm is a leading provider of generic drug serialization and track-and-trace solutions in China, with a market share of over 20%. The company has been at the forefront of implementing advanced technologies to ensure the authenticity and safety of medications.
2. China Resources Pharmaceutical Group
China Resources Pharmaceutical Group is another key player in the Chinese market, with a focus on providing comprehensive serialization and track-and-trace solutions for generic drugs. The company has seen a significant increase in exports, with a trade value of over 100 million RMB in the past year.
3. Shanghai Pharmaceuticals
Shanghai Pharmaceuticals is a well-known name in the pharmaceutical industry in China, offering a wide range of serialization and track-and-trace solutions for generic drugs. The company’s production volume has been steadily increasing, reflecting the growing demand for their services.
4. China National Pharmaceutical Group (Sinopharm)
As one of the largest pharmaceutical companies in China, China National Pharmaceutical Group (Sinopharm) has a strong presence in the serialization and track-and-trace market. With a focus on innovation and quality, the company has gained a significant market share in recent years.
5. Jiangsu Hengrui Medicine
Jiangsu Hengrui Medicine is a key player in the generic drug serialization and track-and-trace market in China, known for its high-quality products and services. The company’s exports have been growing steadily, with a trade value of over 50 million RMB last year.
6. Zhejiang Hisun Pharmaceutical
Zhejiang Hisun Pharmaceutical is a leading provider of serialization and track-and-trace solutions for generic drugs in China, with a focus on compliance and efficiency. The company has seen a notable increase in market share, thanks to its innovative technologies.
7. Fosun Pharma
Fosun Pharma is a well-established name in the pharmaceutical industry in China, offering a range of serialization and track-and-trace solutions for generic drugs. The company has been expanding its production capacity to meet the growing demand for its services.
8. Sino Biopharmaceutical
Sino Biopharmaceutical is a prominent player in the generic drug serialization and track-and-trace market in China, known for its cutting-edge technologies and reliable services. The company’s market share has been steadily increasing, reflecting its strong performance.
9. China Meheco Corporation
China Meheco Corporation is a trusted provider of serialization and track-and-trace solutions for generic drugs in China, with a focus on quality and safety. The company has been investing in research and development to stay ahead of the competition.
10. Harbin Pharmaceutical Group
Harbin Pharmaceutical Group is a key player in the generic drug serialization and track-and-trace market in China, offering a wide range of solutions for pharmaceutical companies. The company has seen a significant increase in production volume, reflecting the growing demand for its services.
Insights:
The market for generic drug serialization and track-and-trace solutions in China is expected to continue growing in the coming years, driven by increasing regulations and demand for safe medications. With the implementation of advanced technologies and a focus on quality and compliance, Chinese companies are well-positioned to meet the needs of the pharmaceutical industry. According to forecasts, the market is expected to reach a trade value of over 500 million RMB by 2023, making it a lucrative sector for investment and growth. Companies that prioritize innovation and efficiency will be able to capitalize on the opportunities in this expanding market.
Related Analysis: View Previous Industry Report
